Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2025-12-29 @ 5:45 AM
Study NCT ID:
NCT01271868
Status:
TERMINATED
Last Update Posted:
2021-03-15
First Post:
2011-01-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
Sponsor:
Medexus Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-06
First Submit QC Date:
None
Study First Post Date:
2011-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-28
Results First Submit QC Date:
None
Results First Post Date:
2019-04-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-02-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-03-11
Last Update Post Date:
2021-03-15
Last Update Post Date Type:
ACTUAL